BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

230 related articles for article (PubMed ID: 17652844)

  • 1. Does mesenchymal stem cell therapy help multiple sclerosis patients? Report of a pilot study.
    Mohyeddin Bonab M; Yazdanbakhsh S; Lotfi J; Alimoghaddom K; Talebian F; Hooshmand F; Ghavamzadeh A; Nikbin B
    Iran J Immunol; 2007 Mar; 4(1):50-7. PubMed ID: 17652844
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bone marrow mesenchymal stem cell transplantation in patients with multiple sclerosis: a pilot study.
    Yamout B; Hourani R; Salti H; Barada W; El-Hajj T; Al-Kutoubi A; Herlopian A; Baz EK; Mahfouz R; Khalil-Hamdan R; Kreidieh NM; El-Sabban M; Bazarbachi A
    J Neuroimmunol; 2010 Oct; 227(1-2):185-9. PubMed ID: 20728948
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Open-labeled study of unilateral autologous bone-marrow-derived mesenchymal stem cell transplantation in Parkinson's disease.
    Venkataramana NK; Kumar SK; Balaraju S; Radhakrishnan RC; Bansal A; Dixit A; Rao DK; Das M; Jan M; Gupta PK; Totey SM
    Transl Res; 2010 Feb; 155(2):62-70. PubMed ID: 20129486
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A long-term follow-up study of intravenous autologous mesenchymal stem cell transplantation in patients with ischemic stroke.
    Lee JS; Hong JM; Moon GJ; Lee PH; Ahn YH; Bang OY;
    Stem Cells; 2010 Jun; 28(6):1099-106. PubMed ID: 20506226
    [TBL] [Abstract][Full Text] [Related]  

  • 5. High-dose immunosuppressive therapy with autologous hematopoietic stem cell transplantation as a treatment option in multiple sclerosis.
    Shevchenko YL; Novik AA; Kuznetsov AN; Afanasiev BV; Lisukov IA; Kozlov VA; Rykavicin OA; Ionova TI; Melnichenko VY; Fedorenko DA; Kulagin AD; Shamanski SV; Ivanov RA; Gorodokin G
    Exp Hematol; 2008 Aug; 36(8):922-8. PubMed ID: 18468768
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Therapeutic plasma exchange combined with immunomodulating agents in secondary progressive multiple sclerosis patients.
    Grapsa E; Triantafyllou N; Rombos A; Lagouranis A; Dimopoulos MA
    Ther Apher Dial; 2008 Apr; 12(2):105-8. PubMed ID: 18387157
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Feasibility of a stem cell therapy for intervertebral disc degeneration.
    Sobajima S; Vadala G; Shimer A; Kim JS; Gilbertson LG; Kang JD
    Spine J; 2008; 8(6):888-96. PubMed ID: 18082460
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical outcomes after autologous haematopoietic stem cell transplantation in patients with progressive multiple sclerosis.
    Xu J; Ji BX; Su L; Dong HQ; Sun XJ; Liu CY
    Chin Med J (Engl); 2006 Nov; 119(22):1851-5. PubMed ID: 17134581
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Application of multipotent mesenchymal stromal cells in pediatric patients following allogeneic stem cell transplantation.
    Müller I; Kordowich S; Holzwarth C; Isensee G; Lang P; Neunhoeffer F; Dominici M; Greil J; Handgretinger R
    Blood Cells Mol Dis; 2008; 40(1):25-32. PubMed ID: 17869550
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A phase I clinical trial of the treatment of Crohn's fistula by adipose mesenchymal stem cell transplantation.
    García-Olmo D; García-Arranz M; Herreros D; Pascual I; Peiro C; Rodríguez-Montes JA
    Dis Colon Rectum; 2005 Jul; 48(7):1416-23. PubMed ID: 15933795
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Improvement of liver function in liver cirrhosis patients after autologous mesenchymal stem cell injection: a phase I-II clinical trial.
    Kharaziha P; Hellström PM; Noorinayer B; Farzaneh F; Aghajani K; Jafari F; Telkabadi M; Atashi A; Honardoost M; Zali MR; Soleimani M
    Eur J Gastroenterol Hepatol; 2009 Oct; 21(10):1199-205. PubMed ID: 19455046
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy and safety of mitoxantrone, as an initial therapy, in multiple sclerosis: experience in an Indian tertiary care setting.
    Singhal BS; Geeta S; Hundalani SG; Menon S
    Neurol India; 2009; 57(4):418-23. PubMed ID: 19770542
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treatment of refractory acute GVHD with third-party MSC expanded in platelet lysate-containing medium.
    von Bonin M; Stölzel F; Goedecke A; Richter K; Wuschek N; Hölig K; Platzbecker U; Illmer T; Schaich M; Schetelig J; Kiani A; Ordemann R; Ehninger G; Schmitz M; Bornhäuser M
    Bone Marrow Transplant; 2009 Feb; 43(3):245-51. PubMed ID: 18820709
    [TBL] [Abstract][Full Text] [Related]  

  • 14. IFATS collection: in vivo therapeutic potential of human adipose tissue mesenchymal stem cells after transplantation into mice with liver injury.
    Banas A; Teratani T; Yamamoto Y; Tokuhara M; Takeshita F; Osaki M; Kawamata M; Kato T; Okochi H; Ochiya T
    Stem Cells; 2008 Oct; 26(10):2705-12. PubMed ID: 18535155
    [TBL] [Abstract][Full Text] [Related]  

  • 15. 5-Azacytidine-treated human mesenchymal stem/progenitor cells derived from umbilical cord, cord blood and bone marrow do not generate cardiomyocytes in vitro at high frequencies.
    Martin-Rendon E; Sweeney D; Lu F; Girdlestone J; Navarrete C; Watt SM
    Vox Sang; 2008 Aug; 95(2):137-48. PubMed ID: 18557828
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fetal olfactory ensheathing cells transplantation in amyotrophic lateral sclerosis patients: a controlled pilot study.
    Huang H; Chen L; Xi H; Wang H; Zhang J; Zhang F; Liu Y
    Clin Transplant; 2008; 22(6):710-8. PubMed ID: 18673377
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of different culture conditions for human mesenchymal stromal cells for clinical stem cell therapy.
    Haack-Sorensen M; Friis T; Bindslev L; Mortensen S; Johnsen HE; Kastrup J
    Scand J Clin Lab Invest; 2008; 68(3):192-203. PubMed ID: 17852829
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The potential use of adult stem cells for the treatment of multiple sclerosis and other neurodegenerative disorders.
    Slavin S; Kurkalli BG; Karussis D
    Clin Neurol Neurosurg; 2008 Nov; 110(9):943-6. PubMed ID: 18325660
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical safety of intrathecal administration of mesenchymal stromal cell-derived neural progenitors in multiple sclerosis.
    Harris VK; Vyshkina T; Sadiq SA
    Cytotherapy; 2016 Dec; 18(12):1476-1482. PubMed ID: 27727015
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Autologous mesenchymal stem cell transplantation in stroke patients.
    Bang OY; Lee JS; Lee PH; Lee G
    Ann Neurol; 2005 Jun; 57(6):874-82. PubMed ID: 15929052
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.